0001213900-20-012825.txt : 20200518 0001213900-20-012825.hdr.sgml : 20200518 20200518162750 ACCESSION NUMBER: 0001213900-20-012825 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200515 FILED AS OF DATE: 20200518 DATE AS OF CHANGE: 20200518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dillione Janet CENTRAL INDEX KEY: 0001489798 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34673 FILM NUMBER: 20889916 MAIL ADDRESS: STREET 1: ONE WAYSIDE ROAD CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CorMedix Inc. CENTRAL INDEX KEY: 0001410098 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 CONNELL DRIVE STREET 2: SUITE 5000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-9500 MAIL ADDRESS: STREET 1: 400 CONNELL DRIVE STREET 2: SUITE 5000 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4 1 doc4.xml PRIMARY DOCUMENT X0306 4 2020-05-15 false 0001410098 CorMedix Inc. CRMD 0001489798 Dillione Janet C/O CORMEDIX INC. 400 CONNELL DRIVE, SUITE 5000 BERKELEY HEIGHTS NJ 07922 true false false false Common Stock 53473.0000 D Phantom Stock 0.0000 2020-05-15 4 A false 5253.0000 0.0000 A Common Stock 5253.0000 5253.0000 D Stock Option (Right to Buy Common Stock) 5.6300 2030-02-25 Common Stock 15000.0000 15000.0000 D Phantom Stock 0.0000 Common Stock 1706.0000 1706.0000 D Phantom Stock 0.0000 Common Stock 2099.0000 2099.0000 D Phantom Stock 0.0000 Common Stock 945.0000 945.0000 D Phantom Stock 0.0000 Common Stock 1126.0000 1126.0000 D Phantom Stock 0.0000 Common Stock 843.0000 843.0000 D Stock Option (Right to Buy Common Stock) 8.3000 2029-01-10 Common Stock 15000.0000 15000.0000 D Phantom Stock 0.0000 Common Stock 1328.0000 1328.0000 D Phantom Stock 0.0000 Common Stock 2728.0000 2728.0000 D Phantom Stock 0.0000 Common Stock 7500.0000 7500.0000 D Stock Option (Right to Buy Common Stock) 2.8500 2028-02-16 Common Stock 8000.0000 8000.0000 D Phantom Stock 0.0000 Common Stock 2679.0000 2679.0000 D Phantom Stock 0.0000 Common Stock 3125.0000 3125.0000 D Phantom Stock 0.0000 Common Stock 4167.0000 4167.0000 D Stock Option (Right to Buy Common Stock) 11.2000 2027-02-21 Common Stock 8000.0000 8000.0000 D Phantom Stock 0.0000 Common Stock 695.0000 695.0000 D Phantom Stock 0.0000 Common Stock 829.0000 829.0000 D Stock Option (Right to Buy Common Stock) 15.1500 2025-08-11 Common Stock 10000.0000 10000.0000 D Phantom Stock 0.0000 Common Stock 283.0000 283.0000 D Stock Option (Right to Buy Common Stock) 9.5500 2026-02-21 Common Stock 19000.0000 19000.0000 D Phantom Stock 0.0000 Common Stock 767.0000 767.0000 D Phantom Stock 0.0000 Common Stock 554.0000 554.0000 D Phantom Stock 0.0000 Common Stock 867.0000 867.0000 D Phantom Stock 0.0000 Common Stock 3062.0000 3062.0000 D Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. These options were granted on 01/10/2019. These options are fully vested. These options were granted on 02/16/2018. These options are fully vested. These options were granted on 02/21/2017. These options are fully vested. These options were granted on 08/12/2015. These options are fully vested. These options were granted on 02/21/2016. These options are fully vested. The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split. /s/ Janet Dillione 2020-05-18